News
News
- SHAREHOLDER ALERT: Barr Law Group Investigating NK, IQDNX, JELD, and MDXG; Shareholders are Encouraged to Contact the Firm
09:00 - GlobeNewswire - INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4
02/25/2021 / 15:00 - GlobeNewswire - Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores
02/25/2021 / 14:45 - GlobeNewswire - Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress
02/24/2021 / 22:01 - GlobeNewswire - Equinor ASA: Correction: Information relating to proposed dividend for fourth quarter 2020
02/24/2021 / 07:51 - GlobeNewswire - Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
02/23/2021 / 14:00 - GlobeNewswire - Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
02/22/2021 / 22:01 - GlobeNewswire - Cullinan Management, Inc. Announces Business Update
02/22/2021 / 13:30 - GlobeNewswire - Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer
02/22/2021 / 13:30 - GlobeNewswire - Medicenna to Present at the Cowen 41st Annual Healthcare Conference
02/22/2021 / 13:00 - GlobeNewswire
Real-time